Tag: eating disorder

Why CBT Reigns as the Top Therapy for Mental Health

🧠💡 CBT Confirmed—Again: Landmark Meta-Analysis Reinforces Clinical Value Across Diagnoses
A massive meta-analysis in JAMA Psychiatry (2025) reaffirms what many of us observe in day-to-day care: Cognitive Behavioral Therapy (CBT) is one of the most effective, versatile, and enduring treatments for adult psychiatric conditions.

🔬 Study at a Glance

  • Pooled data from hundreds of RCTs
  • Assessed CBT’s efficacy across depression, anxiety disorders, PTSD, and eating disorders
  • Found significant, lasting effects across diagnostic categories
  • Highlighted condition-specific variation in effect sizes, but overall CBT consistently outperformed inactive controls

đź“š Real-World Relevance
Imagine a patient with chronic panic disorder who’s failed two SSRI trials and prefers non-pharmacologic interventions. CBT remains a frontline solution—equally relevant for the young adult with bulimia or the veteran with PTSD. These aren’t just data points—they’re the cases we see every day.

🔄 How Does CBT Stack Up Against Other Therapies?
While the study primarily focused on CBT, it reinforces existing literature suggesting that CBT often matches or outperforms alternative modalities like psychodynamic therapy or interpersonal therapy in short-term efficacy—especially when structure, time-limited treatment, and measurable goals are critical.

đź›  Implications for Clinical Practice
âś… Why prioritize CBT?

  • It’s highly adaptable
  • Supported across diverse populations
  • Scalable via group therapy, digital tools, and telehealth

🚧 Barriers to Access:

  • Limited availability of trained therapists
  • Insurance coverage gaps
  • Patient preference for “talk therapy” without structure

âś… Strategies to Overcome Them:

  • Integrate CBT-informed principles into brief med management visits
  • Refer to digital CBT platforms when face-to-face access is limited
  • Advocate for reimbursement parity and expanded training programs

đź“Ž Bottom Line
This study isn’t just academic—it’s a call to action. Prioritizing CBT in treatment planning can lead to better outcomes, broader reach, and more durable recovery. As clinicians, it’s on us to ensure our systems support its accessibility.

đź“– Full Article:
https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2832696

0

Cyproheptadine in Anorexia: Appetite Booster or Waste of Time

Over the past few posts, I’ve been using real cases from my practice to highlight essential teaching points in managing complex conditions. Anorexia nervosa, one of the most severe and high-mortality disorders I encounter, demands a multifaceted approach, especially in critical cases. Recently, I had to explore every possible option to support a particularly challenging case, including cyproheptadine—a medication with potential benefits in anorexia. I decided to dive deeper into the evidence supporting its use. At the end of this post, I’ll share my own experience with cyproheptadine in this case and whether it made a difference in the outcome

Cyproheptadine has been studied in the treatment of anorexia, particularly anorexia nervosa, due to its appetite-stimulating and antihistaminic properties. Some early randomized controlled trials (RCTs) suggested it might have benefits, especially for anorexia nervosa with certain subtypes, but the evidence has been mixed, and it’s not widely recommended in current guidelines.

  1. Weight Gain: Cyproheptadine has been shown in some RCTs to help promote weight gain in individuals with anorexia nervosa, particularly in those with a restricting type of the disorder. However, results have not been consistent across studies, with some trials finding minimal or no effect on weight gain.
  2. Symptom Relief: Cyproheptadine may help reduce anxiety and obsessive thoughts related to food, as its antihistaminic and mild sedative effects can have a calming influence. However, this has not been strongly confirmed across all trials.
  3. Limitations and Side Effects: The mixed evidence may relate to differences in study designs, anorexia subtypes studied, and dosages used. Side effects, such as sedation, have also limited its use, especially in outpatient settings where these effects might interfere with daily functioning.

Overall, while some RCTs have shown cyproheptadine might help with weight gain and symptom relief in anorexia, particularly in non-binging types, the evidence remains inconclusive. In my personal practice with the medication, I saw limited if any benefit by adding this medication to current standard of treatment. We are often looking for solutions to complex difficult to treat conditions such as anorexia, but the benefits here seem to be limitted both from the research and clinical perspective. 

0

Powered by WordPress.com.

Up ↑